Procurement Summary
State: New Delhi
Summary: Supply of Adalimumab Inj- Each Pre-Filled Syringe To Contain: Adalimumab 20Mg/ 0.4Ml Composition Adalimumab 20Mg, Succinic Acid 0.472Mg, Sodium Hydroxide Nf Q.S. To Ph 5.2 Sodium Chloride Usp 2...
Deadline: 07 Jan 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 111216195
Document Ref. No.: No. U-25/12/165 to 169/2024-Medical.V (E-754406)/167
Financier: Self Financed
Purchaser Ownership: Public
Document Fees: Refer Document
Tender Value: Refer Document
EMD: ₹ 73650
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Tenders Are Invited For Supply of Adalimumab Inj- Each Pre-Filled Syringe To Contain: Adalimumab 20Mg/ 0.4Ml Composition Adalimumab 20Mg, Succinic Acid 0.472Mg, Sodium Hydroxide Nf Q.S. To Ph 5.2 Sodium Chloride Usp 2.336Mg, L-Arginine Monohydrochloride Usp 2Mg, Sorbitol Nf 4Mg, Polysorbate 80 Nf 0.04Mg
Wfi Q.S. To 0.4Ml Unit 1 PFS At New Delhi EMD = 73650 Security Deposit = 73650 Annual Turnover =3682500
Supply of Adalimumab Inj- Each Pre-Filled Syringe To Contain: Adalimumab 20Mg/ 0.4Ml Composition Adalimumab 20Mg, Succinic Acid 0.472Mg, Sodium Hydroxide Nf Q.S. To Ph 5.2 Sodium Chloride Usp 2.336Mg, L-Arginine Monohydrochloride Usp 2Mg, Sorbitol Nf 4Mg, Polysorbate 80 Nf 0.04Mg
Wfi Q.S. To 0.4Ml Unit 1 PFS At New Delhi
Documents
Tender Notice